For the Inventor, By the Inventor

Enter assignee name

Bradford, CT, United States of America

Marinus Pharmaceuticals

USPTO Granted Patents = 24

CIPO Patents = 1

EPO Patents = 2

Trademarks = 6

Forward Citations = 257

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Kenneth Shaw (12 out of 52 patents)

Mingbao Zhang (12 out of 25 patents)

Alex Aimetti (8 out of 10 patents)

4. David Czekai (7 out of 7 patents)

5. Joseph Hulihan (7 out of 9 patents)

6. Christopher Cashman (4 out of 4 patents)

7. Lorianne Masuoka (4 out of 4 patents)

8. Jaakko Lappalainen (4 out of 4 patents)

9. Scott Braunstein (4 out of 6 patents)

10. Maciej Gasior (3 out of 3 patents)

11. Julia Tsai (3 out of 3 patents)

12. Raymond C Glowaky (1 out of 7 patents)

13. Alan J Hutchison (1 out of 128 patents)

24 patents: Sort by Forward Citations

1. 12268696 - Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders (2025-04-08),

2. 12246026 - Ganaxolone for use in treatment of status epilepticus (2025-03-11),

3. 12115169 - Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders (2024-10-15),

4. 11980625 - Ganaxolone for use in treating tuberous sclerosis complex (2024-05-14),

5. 11701367 - Ganaxolone for use in treating tuberous sclerosis complex (2023-07-18),

6. 11679117 - Ganaxolone for use in treatment of status epilepticus (2023-06-20),

7. 11266662 - Ganaxolone for use in prophylaxis and treatment of postpartum depression (2022-03-08),

8. 11110100 - Ganaxolone for use in treatment of status epilepticus (2021-09-07),

9. 11071740 - Method of treatment using nanoparticulate ganaxolone formulations (2021-07-27),

10. 11000531 - Methods of treating certain depressive disorders and delirium tremens (2021-05-11),

11. 10780099 - Injectable neurosteroid formulations containing nanoparticles (2020-09-22),

12. 10639317 - Methods of treating certain depressive disorders and delirium tremens (2020-05-05),

13. 10391105 - Methods of treating certain depressive disorders and delirium tremens (2019-08-27),

14. 9452176 - Solid ganaxolone compositions and methods for the making and use thereof (2016-09-27),

15. 9056116 - Liquid ganaxolone formulations and methods for the making and use thereof (2015-06-16),

Marinus Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapeutics to treat rare seizure disorders and neuropsychiatric disorders. Their mission is to improve the lives of patients suffering from these debilitating conditions by delivering novel, effective, and safe treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#1 in Bradford, CT

#312 in Connecticut

#13,426 in US

#25,857 in the World

Bradford, CT, United States of America

Marinus Pharmaceuticals

Forward Citations = 257

13 inventors:

Kenneth Shaw (12 out of 52 patents)

Mingbao Zhang (12 out of 25 patents)

Alex Aimetti (8 out of 10 patents)

4. David Czekai (7 out of 7 patents)

5. Joseph Hulihan (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…